Clinical trial

DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:

NCT04884139

Study summary

ClinicalTrials.gov

DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV:

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Dolutegravir/Lamivudine as a single pill Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Bictegravir/Emtricitabine/Tenofovir alfenamide as a single pill. Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-07-14

PhasePHASE4

Conditions

HIV-1-infectionunresolved

Interventions

Dolutegravir/Lamivudine as a single pillDRUG

Bictegravir/Emtricitabine/Tenofovir alfenamide as a single pill.DRUG

Sponsors & collaborators

Fundacion SEIMC-GESIDAlead sponsor

ViiV Healthcarecollaborator

Mapped research locations

BarcelonaSpain8 MadridSpain5 AlicanteSpain2 Palma de MallorcaSpain2 ValenciaSpain1 SevilleSpain1 A CoruñaSpain1 ZaragozaSpain1 MurciaSpain1 LleidaSpain1 OviedoSpain1 ValladolidSpain1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04884139 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.